SPY - flat this morning as we await the second testimonial day for FED chair Powell. There has been lots of opportunity in small caps the past week so shifting focus there, also to avoid the chop that we see in large cap on Fed days.
OPK - Opko health sign deal for experimental Epstein-Barr virus vaccine. Triple bottom type of action at the 1.00 level. Showing 3...
Looking to take an entry at 1.05 if volume and technicals look promising for Monday. A break below $1 would turn this into a bearish play for me.
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) shareholders (or potential shareholders) will be happy to see that the President, Raul Rodriguez, recently bought a whopping US$688k worth of stock, at a price of US$0.69. That...
Not quite going to Rigel, but showing more and more promise of higher highs in the not so distant future. Looking quite optimal fractally, actually.
Fibonacci goals are in green, reversal or invalidation is in red. This post is not financial advice, make your own financial advice or pay a certified professional ( you are to statistically faire better at blindly...
SMA50/200 as support
OBV > OBV Avg34
Williams %R Crossed -80
Entry 3.65
Stop 3
Target 5.5
I am not a PRO trader. I trade option to test my trading plan with small cost.
The max Risk of each plan is less than 1% of my account.
If you like this idea, please use SIM/Demo account to try it.
NASDAQ:RIGL
Possible Scenario: LONG
Evidence: Price Action, It holds the price at this level and now it's time to go up.
TP1 ~5$ , 10% Profit
Recommendation rating on yahoo finance is 1.7
This is my idea and could be wrong 100%
For the past 7 years, every time RIGL hit $5 -- it gets instantly sold back. Will this time be different? If it breaks past $5, this will be the greatest underdog bull victory in the history of this stock. Which side will you be on? I'm long-- always!
CURRENT PRICE
3.81, at resistance, 3.73 ± 0.101 type single, strength 1
SUPPORT BELOW
-7.9% at 3.51 ± 0.095 type single, strength 2
-14.6% at 3.26 ± 0.088 type double, strength 9
-19.6% at 3.06 ± 0.083 type single, strength 1
Contextual immersion trading strategy idea.
Rigel Pharmaceuticals, Inc., a biotechnology company, engages in the discovery and development of small molecule drugs for the treatment of immune and hematologic disorders, cancer, and rare diseases.
The demand for shares of the company looks higher than the supply.
This and other conditions can cause a rise in the...
Contextual immersion trading strategy idea.
Rigel Pharmaceuticals, Inc., a biotechnology company, engages in the discovery and development of small molecule drugs for the treatment of immune and hematologic disorders, cancer, and rare diseases.
The share prose rose after the company had announced that a drug used to treat an autoimmune disorder will be tested...
Rigel Announces Investigator-Sponsored Trial of Fostamatinib in Patients with COVID-19 Pneumonia.
High content screen identifies fostamatinib as a candidate for repurposing for Acute Lung Injury.
The hallmark of severe COVID-19 is hypoxemia and a radiological pattern of acute lung injury (ALI) that shares features with ARDS. By inhibiting SYK, fostamatinib may...
